The cardiac ultrasound systems market is estimated to secure a valuation of US$ 1.43 billion in 2023. The overall sales of cardiac ultrasound systems are projected to reach US$ 2.33 billion with a CAGR of 5% by 2033.
How are Technological Advancements Influencing Cardiac Ultrasound Systems Sales?
Modern healthcare machines are integrated with artificial intelligence and 4D imaging technologies. These technologies are becoming part of cardiac ultrasound systems, which can now provide excellent 3D images and accurately identify the chief cause of concern during the examination. These machines are made lightweight, portable, and user-friendly to reduce the effort required for operation.
Incorporating wireless mobile connectivity technology with hand-held cardiac ultrasound systems is a game changer in diagnostics. It connects with a mobile or tablet and provides real-time visualization during diagnosis. It also reduces queuing time and facilitates real-time monitoring in hospitals and clinics.
Future Market Insights predicts that modern cardiac ultrasound systems are estimated to completely replace conventional systems due to their high convenience and efficiency. These factors are estimated to boost the sales of cardiac ultrasound systems over the assessment period.
The introduction of diagnostic machine automation and increasing demand for minimally invasive devices are forecast to augment the market growth. The growth can be attributed to faster recovery, reduced stay in the hospital, and attractive design of cardiac ultrasound systems.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Adoption of high-end cardiac ultrasound systems among healthcare providers is fairly limited owing to its high cost. The systems equipped with new and advanced technologies like 4D imaging, Artificial Intelligence, and the Internet of Things are pricier and thus unaffordable for small hospitals and diagnostic centers, especially in developing countries.
Premium machines cost between US$ 120,000 to US$ 130,000, and governments of emerging economies cannot provide sufficient grants to purchase such expensive equipment. It has limited the sales of cardiac ultrasound systems in regions like the Asia Pacific and Latin America.
Lack of awareness among patients regarding cardiac ultrasound systems and stringent regulations is estimated to negatively affect the market growth over the forecast period. The Food and Drugs Administration (FDA) has defined strict regulations to mitigate any harmful side effects that might happen to the human body. These factors and the lack of skilled laborers and expert operators are estimated to further restrain the market growth over the forecast period.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 5% |
| Market Valuation (2023) | US$ 1.43 billion |
| Market Valuation (2033) | US$ 2.33 billion |
As per Future Market Insights (FMI), the global market grew at a steady CAGR of 5% between 2018 and 2022. The market captured a valuation of US$ 1.36 billion in 2022.
Rising cases of heart failure worldwide, along with increasing demand for non-invasive diagnostic methods, have been fuelling the demand for cardiac ultrasound devices. Rapid technological advancements in the field of cardiology and imaging system, along with mounting cases of cardiovascular ailments, are key factors driving growth. Cardiac ultrasound systems sales are estimated to increase at 5% CAGR through 2033.
The growth uptick in cardiac ultrasound systems can be attributed to the increasing prevalence of lifestyle disorders like diabetes and hypertension, which ultimately lead to heart diseases.
The Centers for Disease Control and Prevention states that more than 6 million Americans die from heart failure every year. A similar trend can also be observed in the United Kingdom, China, and India. The high risk of infection and increasing surgery costs prompt patients to look for non-invasive diagnostic systems like cardiac ultrasound. Top manufacturers are developing modern devices with better imaging systems to cater to the increasing demand for cardiac ultrasound systems.
Top market players are incorporating cutting-edge technologies like artificial intelligence (AI) and the Internet of Things (IoT) to counter the rising demand and reduce the mortality rate. The COVID-19 pandemic fueled the demand for cardiac ultrasound devices in hospitals and clinics.
Principal Consultant
Cardiac Ultrasound Systems Market:
| Attributes | Cardiac Ultrasound Systems Market |
|---|---|
| CAGR (2023 to 2033) | 5% |
| Value (2023) | US$ 1.43 billion |
| Value (2033) | US$ 2.33 billion |
| Trends | Increasing demand for diagnostic accuracy, serial monitoring, and real-time visualization. |
| Opportunities | Growing popularity of nonsurgical procedures, increasing cost-effective solutions, rising huge investments, and research and development activities. |
Ultrasound Systems Market:
| Attributes | Ultrasound Systems Market |
|---|---|
| CAGR (2023 to 2033) | 5.5% |
| Value (2023) | US$ 10.02 billion |
| Value (2033) | US$ 17.12 billion |
| Trends | Growing trends of point-of-care, and innovation of portable ultrasound machines. |
| Opportunities | Increasing chronic disease patients, expanding the healthcare sector, rising huge investments, and government initiatives. |
Next-Generation Ultrasound Systems Market:
| Attributes | Next-Generation Ultrasound Systems Market |
|---|---|
| CAGR (2023 to 2033) | 5.8% |
| Value (2023) | US$ 15.2 billion |
| Value (2033) | US$ 26.71 billion |
| Trends | Rising cases of fatal injuries during pregnancy, orthopedic diseases, and cardiovascular. |
| Opportunities | Increasing adoption of advanced ultrasound devices, and adoption of data triangular approach. |
Based on product type, the global market is segmented into cart/trolley cardiac ultrasound devices and compact/ handheld ultrasound scanners. FMI predicts that handheld ultrasound scanners exhibit higher growth; however, cart cardiac ultrasound devices account for the maximum market share over the forecast period.
As handheld cardiac ultrasound scanners assist in identifying and analyzing the areas of concern for effective diagnosis and detecting and inspecting blockage in the heart, it is gaining traction among specialists for treating geriatric people suffering from heart diseases.
With rapid technological advancement, modern cardiac ultrasound systems are coming with built-in 3D and 4D imaging technology, which assist in creating accurate visualization of the heart while making it easy to operate. Various non-radiologists increasingly use handheld ultrasound scanners to aid in clinical examinations or practical procedures.
The overall market for handheld ultrasound systems is expected to reach a market value of over US$ 2,300 million by the end of 2033, growing at a CAGR of 6.5% during the forecast period.
Future Market Insights opines that the hospital segment is estimated to account for the maximum global market share due to the easy accessibility of cardiac ultrasound devices for surgical operations and the availability of expert professionals for operating those cardiac devices.
Ambulatory surgical centers are gaining traction and are expected to exhibit a high growth rate during the forecast period. The uptick can be attributed to the increasing number of emergency surgical procedures in free-standing ambulatory surgical centers. Faster outcomes and minimal hospital stay time offered by surgeries performed in ambulatory surgical centers have encouraged the manufacturers to enter this new segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States is expected to dominate the North American cardiac ultrasound systems market owing to increased cardiovascular disease (CVD) cases and modern healthcare infrastructure. The North American market is forecast to grow at 4.70% CAGR by 2033.
The United States is the global leader in healthcare, and the rising prevalence of heart failure has increased the demand for cardiac ultrasound devices. Emory Healthcare surveyed that around 5 million people in the United States live with congestive heart failure. The survey also highlights that heart conditions are responsible for more than 11 million physician visits and 875,000 hospitalizations among the elder population every year. It is prompting scientists to develop advanced cardiac ultrasound systems.
The presence of top market players like General Electric, Siemens, and Samsung Medison Co. in the country has consistently introduced new products, thus, boosting the market revenue.
Growing consumer inclination towards non-invasive, compact, and portable devices is estimated to also augment the market growth in the United States. Number of heart surgeries has increased significantly due to increasing cases of CVD. The shortage of skilled professionals and cardiologists has increased the demand for more modern devices.
According to the Human Resources and Services Administration, around 17 people die while waiting for a heart transplant daily. To reduce these numbers, experts are opting for cardiac ultrasound devices, resulting in increasing demand for these devices. Growing demand for non-invasive cardiac devices like cardiac ultrasound systems in the United States is estimated to bolster the market growth over the assessment period.
India is forecast to offer lucrative opportunities for market players as the country is one of the fast-growing economies in the world, and the government is investing in expanding its healthcare sector. For instance, the Government of Assam Health and Family Welfare started an initiative in which the state government is estimated to bear the surgery cost for children with heart disease. Such initiatives, rising per capita income and increasing access to quality healthcare facilities, are estimated to positively influence market growth.
In India, coronary heart disease (CHD) and cardiovascular ailment cases have escalated over the past few years, resulting in increased demand for cardiac ultrasound systems. Favorable reimbursement policies and growing insurance coverage are estimated to boost growth nationwide.
The rise in CVD cases can be attributed to the increasing number of diabetes and other lifestyle diseases in India. According to International Diabetes Federation, more than 77 million people have diabetes in India, making it one of the top countries with the highest diabetic population. Diabetes is a root cause of major heart diseases, with 20% of the Indian population succumbing to heart disease.
In its 2020 report, AHA Journal highlighted that around 33% of reported deaths in India are due to coronary heart diseases and heart failures, while a simultaneous uptick in heart failure is observed, especially in the younger population.
The growing burden of heart failure in India and the high demand for non-invasive diagnostic procedures are estimated to boost the demand for cardiac ultrasound systems in the country.
The United Kingdom possesses some of Europe's best and most modern healthcare and medical infrastructure and facilities. Increasing technological advancement in echocardiography and rising incidence of CHD-induced heart failure drive the region's demand for cardiac ultrasound devices.
British Heart Foundation reported that more than 266,000 individuals died due to coronary heart disease in the United Kingdom in 2018. They also predicted that increasing cases of lifestyle disorders like diabetes and hypertension in the country are estimated to increase the death toll in upcoming years.
Growing government initiatives to spread awareness regarding the dangers of CVDs and the side effects of alcohol abuse and bad dietary habits are estimated to drive market growth in the country. Awareness campaigns like "Sudden Cardiac Awareness Month" and "Restart-a-Heart Day" is estimated to positively influence the adoption of echocardiography devices in the United Kingdom.
Increasing investments in integrating advanced technologies like 4D imaging and automation are estimated to create incremental opportunities for the cardiac ultrasound devices market in the country. The rising popularity of minimally invasive devices among patients for the treatment of heart failure is estimated to aggrandize the demand for these systems across the United Kingdom.
According to the Federal Statistical Office, healthcare expenditure in Germany rose by 4% between 2017 and 2018. Germany also spent around 11.7% of its gross domestic product (GDP) on healthcare in 2018. The growing potential patient pool, advanced healthcare infrastructure, and presence of top market players are expected to thrust the market growth in the country.
The rising diagnostics rate and the availability of trained medical experts and cardiologists are estimated to assist Germany in dominating the market. Increasing cases of heart failure and a spike in mortality rate due to CHDs are estimated to boost the adoption of echocardiograms in German hospitals.
Companies are investing in developing cardiac ultrasound systems integrated with hi-tech imaging technology to cater to the growing demand. Based on the factors above, Germany's cardiac ultrasound systems market is forecast to register healthy growth over the assessment period.
Future Market Insights identifies GE Company, Fujifilm, Holdings Corporation, Siemens AG, Koninklijke Philips N.V., Toshiba Medical System Corp., Hitachi Medical Corp., and Esaote SpA as the top market players operating in the global market.
Continuous innovation and development in cardiac ultrasound systems have created cut-throat competition among leading market players. Market players prioritize new product launches and gain approvals from Food and Drugs Administration (FDA) to stay relevant in this highly competitive market.
Other Essential Players in the Global Market are:
Recent Developments in the Global Market are:
For instance, GE Healthcare received 510k U.S. FDA clearance for its ultra edition “Vivid” cardiovascular ultrasound systems in October 2020. This new system is artificial intelligence AI-powered and specifically designed to reduce diagnostic time and enhance measurement consistency. The new AI based features allow clinicians to consistently conduct repeated exams at a faster rate.
In March 2018, Canon Medical System USA launched an upgraded version of Aplio i900 cardiovascular ultrasound system which features superior imaging clarity and helps cardiologists in diagnosing conditions quickly and effectively.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product Type, End User, Region |
| Key Companies Profiled | Hitachi, Ltd.; Analogic Corporation; Toshiba Corporation; Esaote SpA; Samsung Medison Co. Ltd; FUJIFILM Holdings Corporation; Mindray Medical International Ltd.; GE Healthcare |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to reach US$ 1.43 billion in 2023.
The cardiac ultrasound systems market recorded a 5% CAGR from 2018 to 2022.
Increase in cardiovascular disease prevalence and technological advancements.
Navigating stringent regulatory approvals and addressing interoperability issues.
Prominent adoption of cardiac ultrasound systems is observed in the United States, Germany, and Japan.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Cardiac system 5.3.2. Ultrasound system 5.3.2.1. Cart/Trolley Cardiac Ultrasound Devices 5.3.2.2. Compact/Handheld Ultrasound Scanners 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals And Clinics 6.3.2. Diagnostic Imaging And Surgical Centers 6.3.3. Ambulatory Surgical Centers 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Product 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Product 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Product 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product 15.5.2.2. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Product 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Product 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Product 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Hitachi, Ltd. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Analogic Corporation 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Toshiba Corporation 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Esaote SpA 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Samsung Medison Co. Ltd 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. FUJIFILM Holdings Corporation 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Mindray Medical International Ltd. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. GE Healthcare 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Siemens Healthcare 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Trivitron Healthcare 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Cardiac Ultrasound Systems Market
